| scholarly article | Q13442814 |
| P2093 | author name string | Jyh-Cherng Yu | |
| Tzu-Ming Chang | |||
| Ming-Lang Shih | |||
| Teng-Wei Chen | |||
| Chung-Bao Hsieh | |||
| Hsiao-Dung Liu | |||
| Rong-Yaun Shyu | |||
| P2860 | cites work | Expression of 1A6 gene and its correlation with intestinal gastric carcinoma | Q36178290 |
| Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection | Q39433775 | ||
| Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas | Q41965964 | ||
| Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site | Q43517402 | ||
| Tumor volume as a prognostic factor for sarcomatosis | Q44388061 | ||
| The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene | Q44659531 | ||
| Requirement of c-kit for development of intestinal pacemaker system | Q44986124 | ||
| Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging | Q67731122 | ||
| Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas | Q71670124 | ||
| Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand | Q24555963 | ||
| Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors | Q28118852 | ||
| Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management | Q33921674 | ||
| Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor | Q33941495 | ||
| Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. | Q34155715 | ||
| The effect of surgery and grade on outcome of gastrointestinal stromal tumors | Q34214793 | ||
| Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. | Q34250686 | ||
| The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus | Q34407347 | ||
| Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. | Q34506729 | ||
| Clinical management of gastrointestinal stromal tumors: before and after STI-571. | Q34524907 | ||
| Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review | Q34718294 | ||
| Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal | Q34747216 | ||
| Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution | Q34752789 | ||
| Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sa | Q35212601 | ||
| Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era | Q35578992 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 260-263 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Giant malignant gastrointestinal stromal tumors: recurrence and effects of treatment with STI-571 | |
| P478 | volume | 11 |
| Q36426847 | Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment |
| Q37813500 | Giant ileal gastrointestinal stromal tumour presenting as an intestinal subocclusion and subsequent haemoperitoneum: a case report and a review of the literature |
| Q41778247 | Giant rectal gastrointestinal stromal tumors: a report of two cases |
| Q33552139 | Primary Small Bowel GIST Presenting as a Life-Threatening Emergency: A Report of Two Cases. |
Search more.